UC Davis Alzheimer's Disease Core Center

$73,355P30FY2019AGNIH

University Of California At Davis, Davis CA

Investigators

Linked publications & trials

Paper 39677464 Paper 39594552 Paper 39379761 Paper 39254167 Paper 39239892 Paper 39207439 Paper 39173101 Paper 38995966 Paper 38980643 Paper 38958543 Paper 38958117 Paper 38949538 Paper 38915636 Paper 38909025 Paper 38883718 Paper 38759012 Paper 38721926 Paper 38712163 Paper 38669550 Paper 38641585 Paper 38635941 Paper 38586023 Paper 38477469 Paper 38460116 Paper 38441951 Paper 38425303 Paper 38423160 Paper 38418871 Paper 38244935 Paper 38224546 Paper 38194584 Paper 38160359 Paper 38147416 Paper 38007645 Paper 37988169 Paper 37855140 Paper 37840499 Paper 37772658 Paper 37759924 Paper 37712765 Paper 37661877 Paper 37595405 Paper 37592813 Paper 37580727 Paper 37571345 Paper 37528055 Paper 37491248 Paper 37474615 Paper 37355729 Paper 37330193 Paper 37322115 Paper 37307817 Paper 37260021 Paper 37245492 Paper 37212114 Paper 37188790 Paper 37085326 Paper 37057867 Paper 37051669 Paper 37038809 Paper 37021572 Paper 36997127 Paper 36993352 Paper 36970907 Paper 36946449 Paper 36933278 Paper 36840665 Paper 36758620 Paper 36749884 Paper 36722399 Paper 36711704 Paper 36710669 Paper 36692190 Paper 36681388 Paper 36648159 Paper 36628434 Paper 36621368 Paper 36617779 Paper 36577280 Paper 36565204 Paper 36543124 Paper 36530083 Paper 36504357 Paper 36482861 Paper 36448771 Paper 36394443 Paper 36324086 Paper 36314203 Paper 36308307 Paper 36270451 Paper 36264254 Paper 36253382 Paper 36251929 Paper 36220593 Paper 36189595 Paper 36178120 Paper 36157332 Paper 36097795 Paper 36093697 Paper 36062452

Abstract

PROJECT SUMMARY/ABSTRACT For over 25 years the mission of UC Davis Alzheimer's Disease Center has been to advance scientific understanding of Alzheimer's disease and related dementias in communities of color. We aim to supplement and extend our research education component (REC) to support diversification of the ADRD-dedicated minority aging research workforce by collaboration with the University of Texas Rio Grande Valley (UTRGV). The aim of this supplement is to foster the development of a first-rate cadre of researchers from underrepresented minority groups through specific training program that will enable them to create effective new approaches and solutions to understanding and mitigating the complex mechanisms contributing to the disproportionally larger adverse impact of AD among Hispanic patients and their caregivers. This initiative will leverage a unique collaboration the UTRGV AD Resource Center for Minority Aging Research (AD-RCMAR) Partnerships for Progress based at the UTRGV, led by PI Gladys Maestre and funded by NIA in the autumn of 2018. The UTRGV and its School of Medicine (SOM) are new entities in South Texas, and the SOM is the first medical education and research institution in the Rio Grande Valley, a medically underserved border region whose predominantly Hispanic (mostly Mexican-American) population is burdened with dramatic healthcare disparities including diseases that disproportionately afflict minority populations in the US. The AD-RCMAR has already identified as candidates for training and development in ADRD research 50 multidisciplinary junior faculty members, with research interests in 14 academic departments and programs encompassing medicine, nursing, social work, biology, sociology and anthropology, and psychological sciences. Despite the rich and diverse experience of the faculty involved in the AD-RCMAR, the new SOM does not have yet sufficient numbers of AD experts to mentor its new and early investigators. To address this need and accelerate achievement of NIA's mission through its Centers, UCD-ADC and UTRGV AD-RCMAR will collaborate in training and mentoring of UTRGV AD-RCMAR faculty at the UC Center.

View original record on NIH RePORTER →